General
ePRO benefits are Here to Stay Long After COVID-19
We use our smartphones daily, but the adoption of ePRO in the pharmaceutical industry surprising still meets resistance. This opposition is still present even considering
Clinical Research Insights
We use our smartphones daily, but the adoption of ePRO in the pharmaceutical industry surprising still meets resistance. This opposition is still present even considering
Choosing the appropriate data collection strategy has always been a key to success in clinical trials.This is even more important considering COVID-19 and its effects
We take great pleasure in announcing the expansion of our company with the opening of the new office in Potsdam. The metropolitan region of Berlin
We proudly like to announce, that we opened our first German subsidiary on the first of April 2020 in the western part of Germany. The
The time in which the European Medicines Agency did not care about medical devices is over. EMA has published the first of a series of
Since 06 December 2018 the guideline on the content, management and archiving of the TMF is final and will be effective from 06 May 2019
The bad news is “time flies”, the good news is “you are the pilot”. Regulation (EU) 2017/745 (MDR) will apply after a transitional period. Namely,
Why do so many companies run their clinical studies like driving with the car through the fog? In no other industry can you find so